Andrei Seferian

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Anna‐Maria Hoffmann‐Vold, Toby M. Maher, E. Philpot et al. · The Lancet Rheumatology · 2020 · 286 citations

Advanced Lung Disease, Systemic Sclerosis, Pulmonary Fibrosis +3

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

Christophe Guignabert, Carole Phan, Andrei Seferian et al. · Journal of Clinical Investigation · 2016 · 265 citations · Full text

Dasatinib-induced Pah, Dasatinib Treatment, Immunology +17

Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension

Nicolas Ricard, Ly Tu, Morane Le Hiress et al. · Circulation · 2014 · 201 citations

Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

Athénaïs Boucly, Laurent Savale, Xavier Jaïs et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 187 citations

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study

David Montani, Barbara Girerd, Xavier Jaïs et al. · The Lancet Respiratory Medicine · 2017 · 176 citations

Population-based Study, Clinical Phenotypes, Pathology +4